Abstract
Objectives: The aim of this study is to compare the effect of platelet-rich fibrin (L-PRF) and bone morphogenetic protein-2 (rhBMP-2) in management of medication-related osteonecrosis of jaw (MRONJ).Patients and Methods: Among 35 patients who were diagnosed with MRONJ, 12 patients were treated with L-PRF, 12 patients were treated with rhBMP-2 and 11 patients were treated with both L-PRF and rhBMP-2, evaluation of surgical sites was done for each patient postoperatively at 4 and 16 weeks. Results: At 4 and 16 weeks postoperatively, MRONJ treated with both L-PRF and rhBMP-2 showed favorable outcomes with complete resolution of the lesions than that treated with L-PRF or rhBMP-2 alone. However this difference didn’t reach the level of statistical significance (P=0.42). Conclusion: The simultaneous use of both L-PRF and rhBMP-2 in management of MRONJ is a better treatment modality compared to the single use of each one of them alone.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
